Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
SER is expected to report earnings to fall 45.45% to -30 cents per share on March 30
Q4'26
Est.
$-0.30
Q2'26
Missed
by $0.09
The last earnings report on August 13 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 163.36K shares outstanding, the current market capitalization sits at 41.91M.